How to assess the external validity of therapeutic trials: a conceptual approach

被引:158
作者
Dekkers, O. M. [1 ,2 ]
von Elm, E. [3 ,4 ]
Algra, A. [1 ,5 ,6 ]
Romijn, J. A. [2 ]
Vandenbroucke, J. P. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
[3] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland
[4] Univ Med Ctr, Dept Med Biometry & Med Informat, Freiburg, Germany
[5] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Patient Care, Utrecht, Netherlands
[6] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst, Utrecht, Netherlands
关键词
Clinical trial; external validity; RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; MORTALITY; MORBIDITY; CALCIUM;
D O I
10.1093/ije/dyp174
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Methods Methodological review to address the concept of external validity. Results External validity refers to the question whether results are generalizable to persons other than the population in the original study. The only formal way to establish the external validity would be to repeat the study for that specific target population. We propose a three-way approach for assessing the external validity for specified target populations. (i) The study population might not be representative for the eligibility criteria that were intended. It should be addressed whether the study population differs from the intended source population with respect to characteristics that influence outcome. (ii) The target population will, by definition, differ from the study population with respect to geographical, temporal and ethnical conditions. Pondering external validity means asking the question whether these differences may influence study results. (iii) It should be assessed whether the studys conclusions can be generalized to target populations that do not meet all the eligibility criteria. Conclusion Judging the external validity of study results cannot be done by applying given eligibility criteria to a single target population. Rather, it is a complex reflection in which prior knowledge, statistical considerations, biological plausibility and eligibility criteria all have place.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 24 条
[1]   Bias from. requiring explicit consent from all participants in observational research: Prospective, population based study [J].
Al-Shahi, R ;
Vousden, C ;
Warlow, C .
BRITISH MEDICAL JOURNAL, 2005, 331 (7522) :942-945
[2]   Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] study) [J].
Brunner, Martin ;
Cooper-DeHoff, Rhonda M. ;
Gong, Yan ;
Karnes, Jason H. ;
Langaee, Tairnour Y. ;
Pepine, Carl J. ;
Johnson, Julie A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11) :1549-1554
[3]   CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke [J].
Chen, ZM ;
Hui, JM ;
Liu, LS ;
Liu, ZM ;
Peto, R ;
Sandercock, P ;
Wang, WQ ;
Wang, YX ;
Wang, ZB ;
Xie, JX ;
You, GX ;
Zhang, FL ;
Zhang, HQ ;
Zhao, ZY .
LANCET, 1997, 349 (9066) :1641-1649
[4]   Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial [J].
Chen, ZM ;
Jiang, LX ;
Chen, YP ;
Xie, JX ;
Pan, HC ;
Peto, R ;
Collins, R ;
Liu, LS ;
Chen, ZM ;
Liu, LS ;
Collins, R ;
Jiang, LX ;
Chen, YP ;
Xie, JX ;
Pan, HC ;
Peto, R ;
Cai, NS ;
Chen, YZ ;
Cui, JJ ;
Dai, GZ ;
Feng, JZ ;
Fu, SY ;
Gent, M ;
Gong, LS ;
Hu, DY ;
Huang, DJ ;
Huang, J ;
Huang, TG ;
Huang, ZW ;
Hui, RT ;
Jiang, BQ ;
Li, DY ;
Li, SM ;
Li, TD ;
Li, YQ ;
Li, ZQ ;
Liu, YH ;
Meng, QY ;
Qian, TJ ;
San, J ;
Tao, SQ ;
Wang, DW ;
Wang, LH ;
Wang, W ;
Wu, HA ;
Xi, WH ;
Xu, CB ;
Yang, DC ;
Yang, XF ;
Yin, JQ .
LANCET, 2005, 366 (9497) :1607-1621
[5]   LUNG CANCER AND OTHER CAUSES OF DEATH IN RELATION TO SMOKING - A 2ND REPORT ON THE MORTALITY OF BRITISH DOCTORS [J].
DOLL, R ;
HILL, AB .
BRITISH MEDICAL JOURNAL, 1956, 2 (NOV10) :1071-1081
[6]   External validity: We need to do more [J].
Glasgow, RE ;
Green, LW ;
Klesges, LM ;
Abrams, DB ;
Fisher, EB ;
Goldstein, MG ;
Hayman, LL ;
Ockene, JK ;
Orleans, CT .
ANNALS OF BEHAVIORAL MEDICINE, 2006, 31 (02) :105-108
[7]   Rates of hyperkalemia after publication of the randomized aldactone evaluation study [J].
Juurlink, DN ;
Mamdani, MM ;
Lee, DS ;
Kopp, A ;
Austin, PC ;
Laupacis, A ;
Redelmeier, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :543-551
[8]   SINGLE-DRUG THERAPY FOR HYPERTENSION IN MEN - A COMPARISON OF 6 ANTIHYPERTENSIVE AGENTS WITH PLACEBO [J].
MATERSON, BJ ;
REDA, DJ ;
CUSHMAN, WC ;
MASSIE, BM ;
FREIS, ED ;
KOCHAR, MS ;
HAMBURGER, RJ ;
FYE, C ;
LAKSHMAN, R ;
GOTTDIENER, J ;
RAMIREZ, EA ;
HENDERSON, WG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (13) :914-921
[9]   Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss:: A randomized controlled open-label prospective trial [J].
Meier, C ;
Woitge, HW ;
Witte, K ;
Lemmer, B ;
Seibel, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1221-1230
[10]   The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials [J].
Moher, D ;
Schulz, KF ;
Altman, DG .
LANCET, 2001, 357 (9263) :1191-1194